Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Not applicableStudy completedNCT01886235
What this trial is testing

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00026221
What this trial is testing

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 57
Early research (Phase 1)Study completedNCT00658892
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 7
Early research (Phase 1)Ended earlyNCT01123304
What this trial is testing

Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma

Who this might be right for
Melanoma
Morphotek 18
Testing effectiveness (Phase 2)Ended earlyNCT01801358
What this trial is testing

A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Array Biopharma, now a wholly owned subsidiary of Pfizer 38
Not applicableUnknownNCT03033485
What this trial is testing

18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis

Who this might be right for
Melanoma
Xijing Hospital 50
Testing effectiveness (Phase 2)UnknownNCT01092585
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Who this might be right for
Melanoma
Genta Incorporated 27
Testing effectiveness (Phase 2)Study completedNCT02403778
What this trial is testing

Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Who this might be right for
Melanoma
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Study completedNCT00911443
What this trial is testing

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
sigma-tau i.f.r. S.p.A. 488
Testing effectiveness (Phase 2)Study completedNCT01928940
What this trial is testing

Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)

Who this might be right for
Solid Tumours
GlaxoSmithKline 12
Not applicableLooking for participantsNCT07161310
What this trial is testing

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

Who this might be right for
Solid CancerNon-Small Cell Lung CancerMelanoma
Goethe University 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Large-scale testing (Phase 3)Study completedNCT00671918
What this trial is testing

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Who this might be right for
Breast CancerMelanoma
Navidea Biopharmaceuticals 186
Testing effectiveness (Phase 2)Study completedNCT00104897
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Cancer Research UK 25
Testing effectiveness (Phase 2)Study completedNCT01134250
What this trial is testing

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Who this might be right for
Solid TumorBreast CancerMetastatic Melanoma+1 more
Philogen S.p.A. 48
Testing effectiveness (Phase 2)Study completedNCT03110159
What this trial is testing

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Who this might be right for
Skin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more
Medical Dermatology Specialists 8
Early research (Phase 1)Ended earlyNCT03265080
What this trial is testing

ADXS-NEO Expressing Personalized Tumor Antigens

Who this might be right for
Colon Cancer MetastaticHead and Neck Cancer MetastaticMetastatic Non-Small Cell Lung Cancer+2 more
Advaxis, Inc. 13
Early research (Phase 1)Ended earlyNCT03957096
What this trial is testing

A Safety Study of SGN-CD47M in Patients With Solid Tumors

Who this might be right for
Soft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more
Seagen Inc. 16
Next Page